Lev Pavlovsky

1.4k total citations
57 papers, 985 citations indexed

About

Lev Pavlovsky is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Lev Pavlovsky has authored 57 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Dermatology, 27 papers in Immunology and 15 papers in Epidemiology. Recurrent topics in Lev Pavlovsky's work include Psoriasis: Treatment and Pathogenesis (23 papers), Dermatology and Skin Diseases (15 papers) and Cutaneous lymphoproliferative disorders research (9 papers). Lev Pavlovsky is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (23 papers), Dermatology and Skin Diseases (15 papers) and Cutaneous lymphoproliferative disorders research (9 papers). Lev Pavlovsky collaborates with scholars based in Israel, United States and Germany. Lev Pavlovsky's co-authors include Emmilia Hodak, Alon Friedman, Igor Snast, Lihi Atzmony, Daniela Kaufer, Hermona Soreq, Eran Meshorer, Roi Gazit, Nissim Ben‐Arie and David Glick and has published in prestigious journals such as Science, Brain Research and Journal of Investigative Dermatology.

In The Last Decade

Lev Pavlovsky

53 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lev Pavlovsky Israel 17 389 352 179 143 141 57 985
Nicole Pezous Switzerland 11 807 2.1× 138 0.4× 248 1.4× 211 1.5× 149 1.1× 20 1.5k
Yu‐Huei Huang Taiwan 17 359 0.9× 329 0.9× 91 0.5× 124 0.9× 76 0.5× 66 846
J Schnitker Germany 19 129 0.3× 272 0.8× 128 0.7× 60 0.4× 90 0.6× 42 1.2k
Iñaki Izquierdo Spain 24 237 0.6× 224 0.6× 137 0.8× 152 1.1× 206 1.5× 79 1.6k
Mark Watling Italy 16 249 0.6× 85 0.2× 220 1.2× 26 0.2× 142 1.0× 29 982
Ilya Mukovozov Canada 16 87 0.2× 147 0.4× 213 1.2× 125 0.9× 57 0.4× 63 791
Michael Sator Austria 24 141 0.4× 224 0.6× 131 0.7× 80 0.6× 47 0.3× 75 1.5k
Eduardo E. Valdez-Moráles Mexico 12 69 0.2× 80 0.2× 218 1.2× 98 0.7× 77 0.5× 25 889
Tatyana Shaw United States 6 80 0.2× 512 1.5× 234 1.3× 58 0.4× 18 0.1× 8 1.1k
Raquel Guerrero‐Alba Mexico 12 63 0.2× 77 0.2× 203 1.1× 100 0.7× 78 0.6× 29 869

Countries citing papers authored by Lev Pavlovsky

Since Specialization
Citations

This map shows the geographic impact of Lev Pavlovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lev Pavlovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lev Pavlovsky more than expected).

Fields of papers citing papers by Lev Pavlovsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lev Pavlovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lev Pavlovsky. The network helps show where Lev Pavlovsky may publish in the future.

Co-authorship network of co-authors of Lev Pavlovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Lev Pavlovsky. A scholar is included among the top collaborators of Lev Pavlovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lev Pavlovsky. Lev Pavlovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Matar, Manar, Yael Weintraub, Dror S. Shouval, et al.. (2025). Tumor necrosis factor α inhibitor-induced alopecia in pediatric patients: a cohort of 20 patients and review of the literature. Archives of Dermatological Research. 317(1). 799–799. 1 indexed citations
3.
Wolf, Peter, Romana Čeović, Curdin Conrad, et al.. (2024). Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network. Journal of the European Academy of Dermatology and Venereology. 38(8). 1531–1542. 4 indexed citations
4.
Gold, Linda Stein, Stephen K. Tyring, Hwanhee Hong, et al.. (2024). 50251 Efficacy of Risankizumab Versus Apremilast Among Patients with Scalp or Nail Psoriasis from the Phase 4 IMMpulse Study. Journal of the American Academy of Dermatology. 91(3). AB38–AB38.
5.
Pavlovsky, Lev, et al.. (2023). Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy. Photodermatology Photoimmunology & Photomedicine. 40(1). e12936–e12936. 5 indexed citations
6.
7.
Piaserico, Stefano, Elisabeth Riedl, Lev Pavlovsky, et al.. (2023). Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO). Frontiers in Medicine. 10. 1185523–1185523. 20 indexed citations
8.
Aronovich, Anna, et al.. (2023). Do Biologic Treatments for Psoriasis Lower the Risk of Psoriatic Arthritis? A Systematic Review. American Journal of Clinical Dermatology. 24(6). 865–873. 3 indexed citations
9.
Amitay‐Laish, Iris, Batya B. Davidovici, Yael A. Leshem, et al.. (2022). Facial demodicosis in the immunosuppressed state: a retrospective case series from a tertiary referral center. International Journal of Dermatology. 61(10). 1245–1252. 3 indexed citations
10.
Sherman, Shany, et al.. (2020). Ixekizumab Survival in Heavily Pretreated Patients with Psoriasis: A Two-year Single-centre Retrospective Study. Acta Dermato Venereologica. 100(19). adv00349–adv00349. 6 indexed citations
11.
Snast, Igor, et al.. (2019). Active Tuberculosis in Patients with Psoriasis Receiving Biologic Therapy: A Systematic Review. American Journal of Clinical Dermatology. 20(4). 483–491. 22 indexed citations
12.
Sherman, Shany, et al.. (2019). IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience. Acta Dermato Venereologica. 99(9). 769–773. 17 indexed citations
13.
14.
Avni, Tomer, et al.. (2018). Tuberculosis Screening in Patients with Psoriasis Receiving Biologic Therapy: A Retrospective Cohort Study. Acta Dermato Venereologica. 98(10). 979–980. 2 indexed citations
15.
Hodak, Emmilia, Lihi Atzmony, Lev Pavlovsky, Doron Comaneshter, & Arnon D. Cohen. (2017). Hidradenitis Suppurativa Is Associated with Familial Mediterranean Fever—A Population-Based Study. Journal of Investigative Dermatology. 137(9). 2019–2021. 23 indexed citations
16.
Sherman, S., et al.. (2017). Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) Relapsing as Bullous Eruption. Acta Dermato Venereologica. 97(3). 406–407. 2 indexed citations
17.
Szegedi, Andrea, Lev Pavlovsky, Külli Kingo, et al.. (2016). Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice. Acta Dermatovenerologica Alpina Pannonica et Adriatica. 26(1). 11–14. 19 indexed citations
18.
Pavlovsky, Lev, et al.. (2015). Vismodegib for radiation-induced multiple basal cell carcinomas (BCCs) of the scalp. Journal of the American Academy of Dermatology. 73(5). 799–801. 7 indexed citations
19.
Pavlovsky, Lev, Daniel Mimouni, Iris Amitay‐Laish, et al.. (2011). Hyperpigmented mycosis fungoides: An unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype. Journal of the American Academy of Dermatology. 67(1). 69–75. 27 indexed citations
20.
Hodak, Emmilia, et al.. (2010). Trends in dermatologic surgery research over the past decade. European Journal of Dermatology. 20(2). 196–199. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Pezous Breakdown of academic impact, for papers by Yu‐Huei Huang Breakdown of academic impact, for papers by J Schnitker Breakdown of academic impact, for papers by Iñaki Izquierdo Breakdown of academic impact, for papers by Mark Watling Breakdown of academic impact, for papers by Ilya Mukovozov Breakdown of academic impact, for papers by Michael Sator Breakdown of academic impact, for papers by Eduardo E. Valdez-Moráles Breakdown of academic impact, for papers by Tatyana Shaw Breakdown of academic impact, for papers by Raquel Guerrero‐Alba
Rankless by CCL
2026